BFM
MRNA icon

Boothbay Fund Management’s Moderna MRNA Stock Holding History

Boothbay Fund Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.6M Buy
+122,800
New +$6.35M 0.11% 193
2026
Q1 		– Sell
-54,800
Closed -$1.62M – 2325
2025
Q4 		$1.62M Sell
54,800
-130,900
-70% -$3.56M 0.02% 644
2025
Q3 		$4.8M Buy
+185,700
New +$5.18M 0.07% 321
2025
Q1 		– Sell
-28,900
Closed -$1.2M – 1636
2024
Q4 		$1.2M Buy
+28,900
New +$1.38M 0.03% 587
2024
Q3 		– Sell
-3,100
Closed -$368K – 1813
2024
Q2 		$368K Buy
+3,100
New +$392K 0.01% 1089
2024
Q1 		– Sell
-9,300
Closed -$925K – 1807
2023
Q4 		$925K Sell
9,300
-41,600
-82% -$3.5M 0.02% 755
2023
Q3 		$5.26M Buy
+50,900
New +$5.68M 0.12% 202
2022
Q4 		– Sell
-69,600
Closed -$8.23M – 2285
2022
Q3 		$8.23M Buy
+69,600
New +$10.6M 0.21% 72
2022
Q2 		– Sell
-2,300
Closed -$396K – 2513
2022
Q1 		$396K Sell
2,300
-76,000
-97% -$12.8M 0.01% 1433
2021
Q4 		$19.9M Buy
+78,300
New +$22.9M 0.47% 20
2021
Q2 		– Sell
-659
Closed -$8.63M – 2014
2021
Q1 		$8.63M Sell
659
-793
-55% -$115K 0.32% 42
2020
Q4 		$15.2M Buy
1,452
+330
+29% +$33.4K 0.56% 17
2020
Q3 		$7.94M Buy
1,122
+904
+415% +$63K 0.48% 22
2020
Q2 		$1.4M Buy
+218
New +$11.9K 0.1% 286

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Boothbay Fund Management's MRNA Position: Q2 2026 in Review

Boothbay Fund Management increased its Moderna (MRNA) stake by 79% in Q2 2026, buying an estimated $317K and bringing the position to 13,906 shares worth $974K. The position accounts for 0.01% of the portfolio, ranked #1112.

Boothbay Fund Management first reported a position in MRNA in Q4 2018 and has held it in 12 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Boothbay Fund Management held 13,906 shares of Moderna worth $974K as of Q2 2026.
  • Boothbay Fund Management bought 6,134 Moderna shares in Q2 2026, an estimated $317K.
  • Moderna made up 0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1112 holding.
  • Boothbay Fund Management first reported a position in Moderna in Q4 2018 and has held it in 12 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.